The medical contrarians picked to lead health agencies

President-elect Donald Trump has appointed a team of medical contrarians to lead key health agencies, reflecting a shift in health policy priorities. Dr. Jay Bhattacharya, a critic of pandemic lockdowns and vaccine mandates, has been nominated to head the National Institutes of Health (NIH). His appointment aligns with Robert F. Kennedy Jr.'s "Make America Healthy Again" agenda, which aims to reform food safety and health programs. Other nominees include Dr. Mehmet Oz for the Centers for Medicare and Medicaid Services and Dr. Marty Makary for the Food and Drug Administration (FDA). These individuals, while lacking extensive bureaucratic experience, are known for their media presence and controversial views on health issues. Kennedy's agenda includes pausing NIH drug development and shifting focus to chronic diseases, while also targeting the CDC and FDA for perceived corruption and inefficiency. The new administration's approach contrasts sharply with Trump's previous term, which prioritized deregulation for the food and drug industries. Critics express concern over the potential public health implications of these appointments, particularly regarding vaccine safety and the management of health crises. The nominees' backgrounds suggest a significant departure from established public health practices, raising questions about the future direction of U.S. health policy.

- Trump has appointed a team of medical contrarians to lead health agencies.

- Dr. Jay Bhattacharya, a critic of lockdowns, is nominated to head the NIH.

- The new health agenda focuses on reforming food safety and health programs.

- Critics warn of potential public health risks from the new appointees' controversial views.

- The administration's approach marks a significant shift from Trump's previous health policies.